Podcasts about neurologists

Dr. Russell Swerdlow is a Neurologist & Co-Director of the Alzheimer's Disease Research Center at the University of Kansas Health System. Dr. Swerdlow joined NewsTalk KZRG to discuss Alzheimer's Disease awareness and treatment options. Join Ted and Steve every weekday on NewsTalk KZRG!!

Social determinants of health, including housing, food access, insurance status, and structural inequities, significantly influence stroke prevention, recovery, and long term outcomes. These factors affect biological risk, treatment adherence, and disparities in care, even when traditional clinical measures are addressed. This episode highlights practical strategies for integrating screening, leveraging multidisciplinary teams, and identifying opportunities for advocacy to improve patient outcomes. In this episode, Teshamae Monteith, MD, FAAN, speaks with Nneka L. Ifejika, MD, MPH, author of the article "Social Determinants of Health and Their Impacts on Stroke Prevention and Outcomes" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. Ifejika is an adjunct professor of physical medicine and rehabilitation at UT Southwestern Medical Center in Dallas, Texas, and the chief scientific officer of the Division of Academics at Ochsner Health System in New Orleans, Louisiana. Additional Resources Read the article: Social Determinants of Health and Their Impacts on Stroke Prevention and Outcomes Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Full episode transcript available here Dr Monteith: Two patients have the same stroke, but when they return, they have very different outcomes. We can look into some of their comorbidities, but something we don't spend enough time talking about is the social determinants of health. Stay tuned to this discussion. I promise you, you'll become a better neurologist. Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Monteith: This is Dr. Teshamae Monteith. Today I'm interviewing Dr. Nneka Ifejika about her article on social determinants of health and their impacts on stroke prevention and outcomes. This article appears in the June 2026 Continuum issue on cerebrovascular disease. How are you? Welcome to our podcast. Dr Ifejika: Thanks for having me. I'm doing great. Dr Monteith: Great. So, can you introduce yourself to our audience? Dr Ifejika: Sure. I'm Dr. Nneka Ifejika. I am the Chief Scientific Officer of Ochsner Health System in New Orleans, Louisiana. But I'm also a cerebrovascular rehabilitation doctor. I've been practicing for about nineteen years, and am happy and honored to be a contributor to this Continuum Neurology article. It's a really important topic. Dr Monteith: Great. So, what got you into this field, first of all? Dr Ifejika: Well, I was deciding between PM&R and neurology, and I was putting in both match lists. And I thought about it and I leaned toward PM&R, but stroke still had a grasp on my heart and my mind. And so, after I finished my residency, I joined the UT Houston stroke team, and I did a, thankfully did a two-year fellowship and became cross-trained in stroke as well as physical medicine rehab. So, I am a jack of both trades. Dr Monteith: So, you got your way in a way. Dr Ifejika: I did. Dr Monteith: You know, we have a lot of learners that are listening, so it's always, uh, nice for them to be inspired, I think, by people's career paths. So why don't we talk about the objectives of your article? Dr Ifejika: Sure. So, one of the most important things that we wanted to do was make sure that medical students, residents, faculty, and fellows understood the impact of social determinants of health on stroke recovery and stroke rehabilitation. It's not as simple as you have hypertension, hyperlipidemia, we're going to manage your stroke risk factors. Oh, you had an ischemic stroke. You presented in time for the window. We're going to give you endovascular therapy and then modified Rankin scale at hospital discharge in ninety days. No, no, no. The stroke survivor and their caregivers and their family have a lot more to deal with outside of what we look at during the acute stroke hospitalization and post-acute rehabilitation. Things like, can they afford the medication that we're prescribing? Antiplatelet agents or anticoagulation can be extremely expensive. Do they have housing insecurity? Is there food insecurity? What's going on behind the scenes that we are not addressing that can directly impact the admission rate and the readmission rate after we take care of a stroke survivor? Dr Monteith: I love the article because you took a real deep dive into social determinants of health, what they are, why they matter, and what we can do about them. And so why don't we talk a little bit about the NINDS framework for social determinants of health? I think many of us might not be familiar with the framework per se. Dr Ifejika: So, the framework consists of multiple domains specifically that relate to social determinants of health that were published in Neurology a couple of years ago. So, I do hope that people who are hearing this recording actually read them. There are interpersonal domains, there are classic medical domains, there are indeterminate domains, and there are six total domains. And health domains are the last domain. So, things like when it comes to housing insecurity, food insecurity, that's a domain of social determinants of health. When it comes to chronic racism, when it comes to biases that patients experience, those actually impact outcomes. So, there are six separate indices that we're going to get into in detail and how we address them as clinicians, whether it be at the medical student level, resident level, faculty level, to integrate the social determinants of health in our care plans, because we could be doing a much better job. And I think it'll be really important from the interpersonal perspective when we really relate to our patients and their families that we ask these questions. For example, if we're prescribing someone to have treatment for their diabetes mellitus and ha- and, and be taking insulin, if they have housing insecurity and they're in a homeless shelter, they have to leave the homeless shelter during the day. So, what happens to the insulin that we prescribe? These are variables that we are not considering on a regular basis, but they directly relate to compliance. Dr Monteith: Great. So that was one thing I wanted to bring up. We're very good at measuring blood pressure and trying to determine, uh, the association between stroke outcomes and things that we can measure, glucose, lipids, blood pressure. What is the evidence for social determinants of health and stroke outcome? Dr Ifejika: The evidence is growing, and there have been many publications that have come out that are, are going to be highlighted in this article related to structural determinants of health inequities, like structural racism, as well as disparities related to ethnicity and race. There's geographical disparities. For example, a lot of patients are, are primarily concerned about rural versus urban, whether you have access to different post-acute rehabilitation, whether you have access to secondary stroke prevention because you simply don't have the transportation from a, a rural area to get to a drugstore to get things available to you. Social status. There are actually publication related to socioeconomic status and the concerns when it comes to air pollution. So particulate matter 2.5, we know that that has a direct impact on stroke outcomes and health overall, but we don't really think about it as a structural determinant of health inequity. There's several multiple layers of research that have gone on specifically that have been cited in the literature that relate directly to social determinants of health and how we can address them moving forward. Dr Monteith: And what I found interesting in your article in that you gave at least a few examples where social factors like income, education were controlled for, and maybe in large part it is, but even when you control for some of these very obvious social risk factors, you still have inequities. Dr Ifejika: Absolutely. And I think it was really important to show that we had strong peer review evidence behind this, as it wasn't just something that we were creating or hypothesizing about. There have been studies that have been done over this over decades of time, showing the impacts of social determinants of health on outcomes. But the question and concern that we have is we know this growing body of literature continues to expand. What are we doing about it when it comes to education of the future generations of providers who will be caring for this population? Dr Monteith: Before we get into how, you know, what we're going to do about that, let's just kind of put that link, cause the evidence is there. How does it drive biology? Dr Ifejika: It's a great question. So, for example, particulate matter 2.5 in air pollution has been shown to have an existing impact on hypertension, raising your blood pressure. So that's a direct effect of a social determinant of health related to socioeconomic status because people who live in areas with higher air pollution are... They're not green spaces. They live near highways. Those are areas that unfortunately are also impacted by food deserts. Food deserts, if you're not able to get fresh fruits, vegetables, whole foods, increases your risk of developing diabetes, hyperlipidemia, also increases your sodium intake, again, increasing hypertension. These things are all connected to biological determinants. It's just that we're not asking about them necessarily within the social history when we're taking people into the hospital, but they have direct effects. Dr Monteith: Great. Neurologists tend to be busy and, you know, we're... have all of these things that we're being asked to do and chart and click and all of that stuff. And so how can we more readily integrate screening for social determinants of health and that conversation into the work we do? We recognize it's important. We recognize it's an important risk factor. There's a lot of these determinants. So, what is a good way to do so? And I, I know that in the paper you've, you've given different roles to different team players, so I want you to talk about that too, but just kind of even a regular routine office visit. Walk us through a way we can more easily integrate that kind of conversation. Dr Ifejika: It's an excellent question, and what I've recommended that we do in a standard office visit is utilize the time before the visit to send out screeners. So, for example, usually with an electronic medical record, you can send documents before the visit even starts, where people can check off whether they have any concerns regarding housing, food insecurity. They can check out their location of where they live, whether they live near a highway or not near a highway. It's specifically related to socioeconomic status. We can ask about insurance status, whether they have insurance, insured versus uninsured, but then also types of insurance, whether they have Medicaid insurance versus Medicare insurance. Then even drilling even further, type of Medicare insurance, Medicare Advantage versus traditional Medicare, cause all of those things actually play a role in this. Dr Ifejika: And evaluate these things and don't take time during your office visit. Send these screeners out beforehand. Have them be assimilated by your medical staff. Make sure you're utilizing every resource that you have at your disposal to help streamline things, so by the time the person comes in for the visit, you've primed the pump. You have this information already in your hands at your fingertips cause it was sent out in advance, and you have your medical staff already have an understanding of. If they didn't fill it out electronically, give it to them in the lobby. Make sure they have a handwritten copy in the lobby so that when they come into the office visit, you have the information at your fingertips. Dr Monteith: Are there any particular resources that you recommend for those types of screeners? Dr Ifejika: What I've used in the past, if you have patient-reported outcomes, so the PROMIS instruments, that's a good start. It doesn't get into the details of housing insecurity, food insecurity, but it's a good start to help prime questions and to start the conversation during your office visit. In my clinics, I do a PROMIS 27 on every patient, as well as a PHQ-9 for depression on everyone. And then I collect data longitudinally, and I can always drill down on factors that I noticed that could become a problem moving forward. Dr Monteith: Yeah. And then also in your article, you spoke a bit about this impact from the acute presentation in the hospital to rehab. Dr Ifejika: Yeah. Dr Monteith: So why don't you talk about these different entry points where we can really engage our patients and try and help reduce their burden? Dr Ifejika: Sure. So, healthcare can be quite fragmented, and the stroke patient, stroke survivor, and their family member have no grasp of that. They've had a stroke, and they may be going from the ER to the ICU to the stroke unit to the floor to the rehab unit, and we see it as multiple levels of care, multiple types of providers. They see it as one hospital. And the concern that we have is, at those branch points, things get dropped, and we have the opportunity to pick things up at those branch points. So, during the acute care hospitalization-Primarily, that's the establishment of what has happened, how we're gonna treat it, what are the variables that we can control for right now to address those determinants of health moving forward, and to specifically looking at whether they were taking medications before, whether they could afford medications before, what that looks like at hospital discharge. Is there any duplication of medications? If a person is taking Coreg and you prescribe metoprolol, but they still have the Coreg at home, should we have really prescribed the metoprolol? We're just spending money that they may have concerns when it comes to access to care and the cost of these prescriptions. So, it's the responsibility of the acute care physician to kind of look at that. Those are subtle things that we think are subtle, but they add up quickly for the family when it comes to having one group of medications that's the same class and having to buy another type. When it comes to post-acute rehabilitation, it's really an important time to screen for whether the caregiver can handle what's occurring. So specifically, if the caregiver is already burning out and the average length of stay for a stroke patient is five days and they've come to rehab for two weeks, what's gonna happen in the next two years or the next four years? So, during the post-acute rehabilitation phase, it's time to kind of look at that and drill down on those kind of questions. Also, the levels of care, Dr Ifejika: it's really important to look at other levels of rehabilitation, so skilled nursing facilities, making sure people have access to that if they need to, if the caregiver is burned out and they don't have the ability to go straight home. Because acute inpatient rehab, the goal of it afterwards, is to go straight home. It's not to go to another facility. So, you need to have that screener in place when it comes to whether the family can take care of this person, and whether the family can do it in an effective way to prevent them being readmitted. Dr Monteith: Great. I also like that you spoke about kind of the team approach and different roles, both for screening and for intervention, both being very important, especially the intervention. And so why don't you give us a few examples how the team could break up the responsibility and how also for the intervention component that can be done. Dr Ifejika: Sure. So, I broke up the team into several levels. So, the team medically is the medical student, resident, and faculty physician. However, the team also includes the support staff, so your case manager, your social worker, the therapist, physical therapy, occupational therapy, speech therapy, the pastoral services, all these members of the team. You know, sometimes as physicians, we don't read those notes. There's a lot of information in the notes from social work, care coordination, and the therapist. They get down to subtleties cause they're asking questions, for example, "What kind of equipment do you have at home? How many stairs do you have at home? What level of house do you have, one story, two story? If you live in an apartment, do you have an elevator access?" That's important for someone with hemiparesis. When it comes to medications, when it comes to insurance status, when it comes to your ability to have the mechanisms to pay for care as an outpatient, social workers are required to ask these questions cause they have to figure out resources for the patient and their family to help facilitate improved outcomes. So, they have to ask questions regarding these tasks. The concerns are, do we read what they're saying? So, it's really important to interact with them, and if it's not something that you're looking at in the chart, cause we're all so tied to our computers, find where they are in the hospital. Walk by their office and have a chat. Run your list with them, especially for people who you're concerned have vulnerabilities, and make sure that you're setting an example for your medical students with your faculty doing so. If you're looking at it from the medical student, resident, faculty perspective, medical students, listen. This is your opportunity to really contribute to the team as well as learn about social determinants of health and research in their fields. You are the boots on the ground for the medical team. You are the ones who should be priming the pump and asking these questions of the family members. We're sending you into the rooms to do a history and physical. Social determinants of health should be a part of your history and physical, and you should be taking what we're saying in this article and asking these questions and tying it into your resident. Now, the resident is the work person of the hospital. We all know this. Things run through the resident. Things run through the fellow. It's really important that they have this information in a manner that is negotiable. The list keeps getting longer, and a resident doesn't need to be overburdened. It needs to be synthesized in a manner that can help facilitate the resident being able to act as well as communicate any concerns to the faculty. And at the faculty level, we are the voices that can affect change. So, if there's any concerns when it comes to advocacy, research, making sure that people are accessing care in a way that makes sense, particularly when it comes to the ability for us to galvanize change on a national level, that's kind of our job. Dr Monteith: Great, and so let's talk about intervention. What are things that, let's say, the neurologist can do to deal with some of these social factors? Dr Ifejika: From the neurology perspective, I think it's really important to identify missed opportunities and making sure that we address them. For example, the conversations around the ability to have access to care related to insurance versus no insurance. There are many, many ways that neurologists are able to advocate for a person being able to get to Medicare insurance, particularly in the outpatient setting. When we see patients in clinic, it takes two years, them, to qualify for Medicare, two years at a minimum. But there's a gap there that can be filled by us making sure that we document what's happened, contact their providers, facilitate communication with their employers, if they're employees, they can get some short-term disability benefits to help bridge that gap prior to receiving Medicare insurance. It behooves us to do this because if we do not, they fall into the gap and they get readmitted and they're back on service anyway. So, what's important is the outpatient that we really kind of focus on things that we can impact and things like insurance and getting people transitioned from having employer-based insurance versus getting to Medicare is a really important way that we can effect change in a, in a way that's viable and, and replicable. So, in the outpatient setting, neurologists have a wonderful opportunity to effect change in social determinants of health. When it comes to employed persons, who had a stroke transitioning to Medicare, it takes two years to do so. So, in the outpatient clinic, if you have an employed person, make sure that you fill out their short-term disability benefits forms, their long-term disability benefits form. Bridge the gap. Get that information to their employer so they can maintain constant coverage. Because if they do not, if they have to choose between refilling medications and putting food on the table, they're going to choose putting food on the table, and that's going to directly impact their outcomes if they're not taking the medication that we recommend. Dr Monteith: I think that's a great point. I mean, there's a lot that we can do, and in some ways, it may not take that much to document and to be able to ask the questions and to include some of that information into the assessment and plan is really a, a great idea. Dr Ifejika: And you know, if we don't bring these things up and have these conversations, it doesn't get addressed. And that's why I'm very, very thankful that I had the opportunity to do so, cause this is a part of what I do all day. I think that if I wasn't integrating these kind of conversations into my practice, I wouldn't have the ability to share these tips and these abilities to move things forward in a manner that will be constructive for our field overall and for our patients. Dr Monteith: And towards the end of the article, you brought up something I think we don't see in many articles, and that's the role of advocacy and getting involved in health policy. So, can you talk a little bit about that? Dr Ifejika: You know, it's really important to facilitate change when you see that there are things that need to be changed. And the best way to do that is through advocacy at the local or state or federal level. A lot of these variables that we're dealing with can be addressed through legal changes. I'll give you an example. End-stage renal disease, if you have immediate hemodialysis and you have that requirement upon hospital discharge, you qualify for Medicare immediately. Immediately. Before you even leave the hospital. Why wouldn't something be similar for a stroke? Well, the reason why is because there was a level of advocacy that came around end-stage renal disease and a member of Congress's wife had hemodialysis requirements. And so, a law was passed to make sure Medicare covered it immediately after hospital discharge. So, it requires advocacy in some significant ways to get things done, but we have the bandwidth to do this. We take care of a population that has some of the highest rates of preventable disability. That's not going away. We need to make sure that we're effecting change for this group to make sure that they have the best possible outcomes they can experience. Dr Monteith: So, any final messages for our listeners? Dr Ifejika: I look forward to hearing everyone's feedback about our issue. I am thankful for the opportunity to talk about, address, and write about this important topic, and look forward to everyone's feedback. Dr Monteith: Well, thank you so much for being on our podcast. It was a really wonderful summary and we had a very thorough conversation, but you didn't give away too much, so I think they're going to have to read the article. Dr Ifejika: You're going to have to read the article. And we want medical students, residents, fellows, faculty, all of our ancillary staff within the hospitals, please read this article. We really appreciate it. Dr Monteith: Again today, I've been interviewing Dr. Nneka Ifejika about her article on social determinants of health and their impacts on stroke prevention and outcomes. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Send us Fan MailWhat makes you you?Is it your memories? Your personality? Your sense of humor? Your motivation? What happens when a neurological disease changes one of those things?In this episode of Causes or Cures, Dr. Eeks talks with neurologist, neuroscientist, and author Dr. Masud Husain about his new book, Our Brains, Our Selves: What a Neurologist's Patients Taught Him About the Brain.Drawing on the stories of seven patients with different neurological conditions, Dr. Husain explores how changes in the brain can profoundly affect identity, behavior, memory, motivation, humor, and our relationships with others.We discuss pathological apathy after stroke, personality changes caused by frontotemporal dementia, memory and Alzheimer's disease, the neurological basis of humor, and how cultural and spiritual beliefs shape the way people understand illness. We also explore bigger questions about free will, responsibility, consciousness, and whether there may be aspects of human experience that lie beyond a purely biological explanation.Dr. Husain shares what decades of caring for patients with neurological disorders have taught him about the brain—and about what it means to be human.Dr. Masud Husain is Professor of Neurology and Cognitive Neuroscience at the University of Oxford and a Professorial Fellow at New College, Oxford. His work spans neurology, neuroscience, psychology, and brain imaging, with a focus on understanding how the brain supports cognition in both healthy individuals and people with neurological disorders. He is also Editor-in-Chief of Brain, one of the world's leading and most influential neurology journals. Our Brains, Our Selves is his first book.Work with me? Perhaps we are a good match. Keep Causes or Cures Ad-Free with Listener SupportYou can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Follow Public Health is WeirdOr Facebook here.On Youtube.Or TikTok.SUBSCRIBE to her Newsletter here! (the bits not posted on socia media)Support the showSupport the show

Epilepsy is a brain condition that causes repeated episodes of sudden, brief changes in the brain's electrical activity causing seizures or convulsions. It's thought 50-million people have the condition, which can't be cured. The right treatment can alleviate symptoms but diagnosis and treatment is limited in many countries.Consultant neurologist Sofia Eriksson is from Sweden and works in the UK at University College London Hospital where she used to be the hospital's clinical lead for epilepsy. She's president elect of the British Association of Neurologists. Sofia says it's important more people talk openly about the condition to help stop people who have it feeling so isolated.Betty Barbara Nsachilwa had her first seizure when she was 13 years old. It took 18 months to find the right medication that has kept her seizures under control since. She says she's been lucky to have the support of her family and colleagues but says many others in Zambia face discrimination and stigma. Betty Barbara co-founded the Epilepsy Association of Zambia in 2001 to increase awareness and education about the condition and support others living with epilepsy.(Image: (L) Betty Barbara Nsachilwa, courtesy Betty Barbara Nsachilwa. (R) Sofia Eriksson, credit Hannah Lovell.)

"There is no one magic test for brain health,” says Richard Isaacson, MD.    Isaacson is a Harvard-trained neurologist who directs the Precision Prevention Program at Atria Health and Research Institute and founded the world's first Alzheimer's Prevention Clinic at Weill Cornell Medicine/NewYork-Presbyterian. A leader in precision-medicine approaches to Alzheimer's risk reduction, he has served as principal investigator for multiple research initiatives focused on individualized care. He recently led an NIH-funded clinical trial showing that a free online tool (RetainYourBrain.com) reduced Alzheimer's risk by 16% in six months, and is working to democratize brain health testing through an at-home, lower-cost blood biomarker test (AlzLabs.org). Show notes: 00:00 - What we don't know about Alzheimer's 04:49 - Where to start with Alzheimer's risk 06:55 - Lifestyle first: optimizing what you can control 10:39 - Using wearables & health tech for brain health 16:19 – Why there's no perfect blood test for the brain 29:06 - Cutting through the information noise 31:10 - Steps to take when symptoms appear 35:37 - Is it actually memory loss? 38:54 - The future of Alzheimer's testing Referenced in the episode:  Free cognitive risk & assessment tools: retainyourbrain.com Free information about blood biomarkers: ind.org/bloodtest   Free information about home testing: alzlabs.org We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Sleep Disturbances in Autism and Neurodivergent Conditions: A Discussion with Dr. Beth Malow, MD, Neurologist and Sleep Disorder Expert Dr. Malow, discusses how sleep problems affect approximately 80% of individuals on the autism spectrum and family members, emphasizing that improving sleep can positively impact every aspect of an autistic person's life and the life of the family. She explained that sleep deprivation exacerbates existing challenges and can lead to irritability and impaired social communication, which are already core features of autism. Beth framed sleep as a “window” to help autistic individuals and families, contrasting this positive approach with the common tendency to focus on difficult behavioral patterns when sleep issues occur.Find out more on our website!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Medical ketogenic therapy has more than 100 years of evidence behind it - so why is it still often treated as a last resort?! Ketogenic dietitian Neha Kaul explains how success can go beyond potential seizure reduction, and how the diet may affect cognition, mood and overall quality of life. Neha also covers common misconceptions, safety concerns, and what it really takes to make the diet work in everyday life.This episode is sponsored by Kanso, a brand by Dr. Schär and had no influence over the editorial content or discussion. Learn more about Kanso here: kanso.com/enChapters

Neurologist and End of Life Experiencer, Dr. Eben Alexander, joins the program to share his remarkable near-death journey and the profound insights it gave him into the nature of consciousness and human existence. We discuss how the materialist framework that has dominated modern science for over a century has clearly stunted human development by dismissing consciousness and anything that cannot be physically touched or measured as “non-science.” Now, with the rise of quantum physics and deeper scientific exploration into human consciousness, science may once again be helping move humanity into a new era of understanding and development. Dr. Alexander shares why he believes science and spirituality are no longer opposing forces, but are instead converging into a deeper understanding of reality itself.You can learn more about his work and take free classes at EbenAlexander.comSee exclusives and more at SarahWestall.Substack.comHelp keep this show on air by supporting my affiliates at SarahWestall.com/shop

Send us Fan MailThink about the last time your head hurt. Headaches are a common condition and one of the most common causes of pain and a major reason people miss work or school and visit a doctor according to the National Institute of Neurological Disorders and Stroke. There are different reasons we get headaches, different tests to learn more about the headaches and different treatments. Hyun Ah Kim, M.D., is a neurologist with Texas Tech Physicians neurology and an assistant professor in the School of Medicine at TTUHSC. She specializes in treating headaches, migraines, vascular vertigo, and autonomic disorders.

What makes us who we are? How do memory, motivation, empathy, judgment, and our sense of belonging shape the way we lead, make decisions, and connect with others? And what happens when those essential cognitive functions begin to change? Join host Michael J. Keegan as he explores these questions and more with Dr. Masud Husain author of Our Brains, Our Selves: What a Neurologist's Patients Taught Him About the Brain.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Neurologist Majid Fotuhi is leading the charge in revolutionising how we understand human intelligence, brain health and age-related cognitive decline. By uncovering the true wonder of how the brain works and its infinite potential for growth and change, Majid will reveal how targeted lifestyle changes can prevent, treat, and even reverse cognitive decline. Following Majid's 12-week programme, more than 80% of patients achieve exceptional improvements in memory, focus and other cognitive functions. In elderly patients with mild cognitive impairment, MRIs show a 3% increase in the volume of the hippocampus, the key brain region for learning and memory. Drawing on these clinical trials, Majid will provide essential strategies to optimize brain health through diet, sleep, and managing stress. Majid will also offer practical, scalable techniques to enhance memory, problem-solving, and focus. Learn more about your ad choices. Visit podcastchoices.com/adchoices

As a busy physician mom or dad, you put everything into your practice and your kids, meaning you want to make sure you're doing the absolute right thing with the money you earn. But when it comes to safeguarding your family's future, is the life and disability insurance offered through your hospital or employer actually enough? Nate Reineke and Chelsea Jones tackle a "doozy" of a listener question from a Pulmonary Critical Care physician in Florida who asks, “I have life and disability insurance at work... do I need more?” We dive deep into the specialty trap of group disability, explaining why standard workplace policies often lack true "Own-Occupation" protection. Without this crucial distinction, you could be left empty-handed if an illness or injury prevents you from practicing pulmonary critical care specifically, even if you are technically healthy enough to work a general job elsewhere. Furthermore, employer-sponsored payout caps fail to cover a doctor's real-world financial needs, making it nearly impossible to simultaneously keep up with household bills, fund college savings, and stay on track for retirement. We also play a round of “asking for a friend” and answer your colleagues' questions. An ENT in New York says, “I have a whole life policy that I want to get out of, but I don't qualify for low-cost term insurance anymore. What should I do?” A Neurologist in California wonders, “My in-laws want to contribute money to my children's college funds each month. Should we have them do a grandparent 529? I've heard they're more beneficial.” A Dermatologist in New Hampshire asks, “Our circumstances have changed, and we now need to buy a bigger house while raising our children. We don't want to lose progress on our college and retirement plans. How should we consider this decision?” Are you ready to turn worries about taxes and investing into a plan for college and retirement? If you're evaluating your options and want to learn more, visit physicianfamily.com and click 'Get Started' or you can ask a question of your own by emailing podcast@physicianfamily.com. See marketing disclosures at physicianfamily.com/disclosures

I clicked on one migraine reel a few weeks ago, and now my Facebook feed will not let me forget it. Dr. Painkiller is back, this time telling women that the things you think are helping your migraines are actually making them worse. Sleeping in. Skipping meals. Not taking your meds fast enough. And of course… your “migraine brain” loves routine, not chaos. In this episode, I'm breaking down what he gets wrong and why this kind of advice keeps women stuck. You don't have a defective brain. You have a body that has lost its resilience, and the standard neurology playbook of “take the medication early, never miss a dose, stay on a perfect schedule” is exactly what turns episodic migraines into chronic ones. I share what's really going on when sleeping in or waking up too early triggers a migraine, why “rebound” isn't a personal failure, and what your body is actually asking for instead. If you're ready to address the root drivers of your migraines, you can book a free consultation at the link below: https://www.drlesliecisar.com/apply Free Training: 5 Proven Steps to Being Migraine Free (Even if you think you've already tried everything.) https://www.drlesliecisar.com/5SHMN Connect with us: Website: https://www.drlesliecisar.com/ Free Facebook Group: Healing Migraines Naturally, with Leslie Cisar, ND Ready to try something radically different that actually works? Read more about my approach here: https://www.drlesliecisar.com/map In health,Dr. Leslie Cisar

What if one of the most promising frontiers in Alzheimer's research isn't just about what's building up in the brain - but how the brain clears it out? In this episode of Research Renaissance, host Deborah Westphal sits down with Dr. Tirth Patel, a neurologist and physician-scientist at UCLA and 2025 Toffler Scholar, to explore the cutting-edge science of brain clearance, tau protein, and the newly discovered lymphatic vessels surrounding the brain.This is a conversation about curiosity, persistence, and the kind of early-career science that could reshape how we understand and treat dementia.What You'll Learn in This EpisodeWhat tau protein is, why it "gunks up" the brain, and how it differs from amyloid beta in Alzheimer's diseaseThe recently discovered lymphatic vessels in the brain's meninges - and why they matter for clearing toxic proteinsHow sleep deprivation spikes tau and amyloid levels in the blood, and what that means for long-term brain healthThe glymphatic system: the brain's internal waste-clearance highway and its deep connection to sleepWhy aging slows down the brain's lymphatic drainage - and what researchers are doing about itThe genetics of Alzheimer's: the difference between causative mutations (APP, PS1, PS2) and risk factors like APOE4New FDA-approved blood tests and the promise of tau PET scans for better diagnosis and stagingThe latest treatments for Alzheimer's - how they work, their limitations, and what's coming nextWhy failure is one of the most undervalued tools in science - and what's missing in how the field handles negative dataA candid take on AI in biological research: where it helps, where it falls short, and whether it lets scientists failAbout Our GuestDr. Tirth Patel is a neurologist and physician-scientist at UCLA, currently working in the lab of Dr. Jason Hinman. His research focuses on how the brain's meningeal lymphatic vessels clear tau protein from the brain to the bloodstream - a question with major implications for Alzheimer's disease and related dementias. Dr. Patel is a 2025 Toffler Scholar, supported by the Karen Toffler Charitable Trust. He is also the co-host of the podcast Recreational Science, where he and his colleague Dr. Lou Yang explore wacky but well-designed scientific studies to illuminate the scientific method.

For the nearly one million Americans living with Parkinson's disease, the space between neurology appointments can feel like a void — symptoms shift, medications need adjusting, and urgent questions pile up with nowhere to turn. That gap in continuous care is exactly the problem Rune Labs set out to solve. With its StrivePD app, Rune Labs has built a platform powered by FDA-cleared movement analysis and one of the largest real-world Parkinson's datasets in existence. Now, the company is going further — launching an AI caregiver directly inside the app: a coordinated system of specialized AI agents, including a Medication Assistant, Symptom Expert, and PD Coach, that deliver personalized, evidence-based guidance based on each patient's own real-time data. In this episode of Digital Health Talks, host Megan Antonelli sits down with Amy Gordon Franzen, the new CEO of Rune Labs, to explore how the company is redefining what it means to support patients not just in the clinic, but every moment of every day. From the science behind the platform to the policy, trust, and ethical questions that come with deploying AI in a chronic disease setting, this is a conversation about what the future of neurological care can actually look like — and who gets to shape it. Amy Gordon Franzen, CEO, Rune Labs Megan Antonelli, Chief Executive Officer, HealthIMPACT

Westchester Magazine's 2026 Healthcare Heroes Luncheon united an inspiring community to celebrate the extraordinary individuals whose dedication has profoundly shaped regional healthcare. Held on Thursday, May 14th, at Mulino's at Lake Isle Country Club in Eastchester, NY, the event provided guests with a meaningful afternoon dedicated to honoring and connecting with this year's honorees. Recognized for their exceptional compassion and excellence, the remarkable stories of these distinguished professionals will be featured in the upcoming May issue of Westchester Magazine.Dr. Fawaz Al-Mufti, a neurologist, neurocritical care specialist, and neuroendovascular surgeon with the Westchester Medical Center and New York Medical College, shared his professional journey with host Bob Marrone. He described the high-stakes reality of treating neurological catastrophes—such as brain hemorrhages, ruptured aneurysms, and acute ischemic strokes—both through emergency procedures and intensive care management. Dr. Al-Mufti, who began his medical career in emergency medicine with Doctors Without Borders, also serves as the Associate Dean for Research and Innovation at New York Medical College, where he oversees a broad range of medical research. Expressing deep passion for his field, he emphasized that it is an absolute privilege to care for his patients and credited his success to the collective efforts of his team at the Brain and Spine Institute.

Moderator: Georg Starke (Munich, Germany) Guest: Giulia Di Rauso (New York, USA) In this episode, Georg Starke speaks with Giulia Di Rauso about trustworthiness and the use of artificial intelligence in neurological research and clinical practice. They discuss explainability, data quality, interpretability, and human oversight in AI systems, highlighting key considerations for responsible integration of AI tools into neurology and the importance of maintaining clinical judgement.

What happens when the world tells you who you are before you ever get the chance to decide for yourself? In this episode of the Starter Girlz Podcast, Jennifer Loehding sits down with recording artist, songwriter, and autism advocate B Able for a conversation about identity, resilience, creativity, and rewriting the narrative others place on you. After being told by a neurologist that he would never attend a regular school, finish high school, go to college, or live a normal life, B Able spent years navigating bullying, misunderstanding, financial hardship, and periods of instability. But through music, self-expression, and an unwavering belief in his purpose, he began building something far bigger than a career. His message became the foundation of his mission: “See the able, not the label.” This conversation explores the connection between creativity and healing, the hidden strengths that can exist inside neurodivergence, and what it looks like to pursue a dream while still figuring yourself out in real time. From mental health and music to discipline, growth, and self-belief, this episode is a reminder that transformation rarely happens in a straight line.

Send us Fan Mail*Details of this episode where correct at the time of recording and may have changeWelcome back to Headfirst: A Concussion Podcast. Today, we're thrilled to have the esteemed Dr. Nitin Sethi.Dr. Sethi is a former boxing and UFC ringside neurologist and a board-certified neurologist specializing in epilepsy and clinical neurophysiology. Dr Sethi holds additional certifications from the American Board of Psychiatry and Neurology in epilepsy and sleep medicine, as well as from the American College of Sports Medicine and the Association of Ringside Physicians as a Certified Ringside Physician. In addition to his numerous publications and his book, Neurologist at Ringside, Dr. Sethi has received several notable appointments and awards, including: The Certificate of Congressional Recognition "Heroes Humanity Award" from U.S. Congresswoman Grace F. Napolitano, awarded on behalf of the World Boxing Council (WBC) for his service to communities in need. Recognition as a Leading Physician of the World and Top Neurologist in New York by The International Association of HealthCare Professionals in 2012. Appointment as Vice Chairman of the Sports Neurology Section of the American Academy of Neurology (AAN) from 2022 to 2024. Serving as an Unaffiliated and Independent Neurotrauma Consultant for the NFL from 2013 to the present. Being a Ringside Panel Physician for the New York State Athletic Commission since 2012.  00:30 - About Dr Nitin Sethi05:00 - What Is a Concussion? 07:05 - Pre and Post-Fight Assessments 12:45 – Role of Ringside Physician 16:40 – Mentality of the Sport 18:10 – Difficult in Subjectivity of Concussion and Sporting Culture24:20 - How Too Change the Sporting Culture29:00- UFC 244 Welterweight Main Card Jorge Masvidal vs Nate Diaz and the Fallout41:15 - Positives of Combat Sports Book: Neurologist at Ringside – Amazon.comJournal Articles-       To be or not to be ringside? Ethical issues pertaining to combat sports medicine: https://www.tandfonline.com/doi/full/10.1080/00913847.2022.2043129-       Neuroimaging in professional combat sports: consensus statement from the association of ringside physicians: https://www.tandfonline.com/doi/full/10.1080/00913847.2022.2083922-       Care of The Older Fighter: Position Statement of the Association of Ringside Physicians: https://www.tandfonline.com/doi/full/10.1080/00913847.2024.2344227Subscribe, review and share for new episodes which will drop fortnightlySocial media:Twitter: @first concussionFacebook: Headfirst: A concussion podcastInstagram: Headfirst_ Concussion  Email: headfirstconcussion@gmail.com 

In this episode, I'm reacting to another Facebook reel making the rounds, this time from a neurologist who claims that migraine brains are simply “wired differently” and groups migraine sufferers in with neurodivergence like ADHD and autism. I push back hard on this idea, because I think it sets women up to give up on healing before they even start. My core point is that what you believe about your migraines shapes how you handle them. If you believe your brain is permanently defective, you'll spend your life suppressing symptoms instead of looking at root causes. I explain why things like hypersensitivity to light, sound, and smells, plus brain fog, are actually textbook signs of metabolic waste and toxin overload, not a permanent brain wiring problem. You weren't simply born this way, and there is a real path forward when you start addressing the actual drivers behind your migraines. If you're ready to address the root drivers of your migraines, you can book a free consultation at the link below: https://www.drlesliecisar.com/apply Free Training: 5 Proven Steps to Being Migraine Free (Even if you think you've already tried everything.) https://www.drlesliecisar.com/5SHMN Connect with us: Website: https://www.drlesliecisar.com/ Free Facebook Group: Healing Migraines Naturally, with Leslie Cisar, ND Ready to try something radically different that actually works? Read more about my approach here: https://www.drlesliecisar.com/map In health,Dr. Leslie Cisar

In this week's episode we interview Kinanah Yaseen, MD, a rheumatologist from Cleveland Clinic's department of rheumatic and immunologic diseases about using ultrasound for giant cell arteritis. ·        Intro by Adam J. Brown, MD 0:12 ·        Dr. Brown's recent patient 1:34 ·        History of ultrasound and GCA 3:20 ·        Episode overview 7:05 ·        History of echolocation; how bats helped us invent ultrasound 8:00 ·        What is a bat bomb? 14:56 ·        How the Titanic helped us invent ultrasound 16:48 ·        Neurologists bring ultrasound to medicine 20:09 ·        OB/GYN is next to use ultrasound 23:11 ·        Ultrasound image quality becomes better 26:32 ·        Ultrasound use in giant cell arteritis 28:44 ·        Welcome Kinanah Yaseen, MD 33:49 ·        Using ultrasound in the clinic 34:25 ·        Can you walk us through an ultrasound of the axillary and vertebral arteries? 37:16 ·        Can you tell us why we stopped looking for sites to biopsy by finding narrowing of the vessels?  38:19 ·        Tell us about the halo sign 39:10 ·        How do you validate your ultrasound skills? 40:20 ·        If we start a patient on steroids, how useful is an ultrasound? 42:35 ·        Episode summary 44:20 ·        Thank you for listening 45:57 We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. Kinanah Yaseen, MD, is a is a staff member of Cleveland Clinic's department of rheumatic and immunologic diseases. References: Friedman, G, et al.Isr J Med Sci. 1988 Kaproth-Joslin K A, et al. Radiographics. 2015 ;doi:10.1148/rg.2015140300 Puéchal X, et al. Lancet. 1995;doi:10.1016/s0140-6736(95)92626-7 Schmidt W A, et al. Lancet. 1995;doi:10.1016/s0140-6736(95)93005-1 Sigel B. Ultrasound Med Biol. 1998;doi:10.1016/s0301-5629(97)00264-0 Editor's Note: This has been updated to include references.

Casey Kozak discusses the process of applying to neurology residency. This episode offers insights for applicants and for neurologists who guide and mentor the next generation of neurologists. 

This week's episode of the Brain & Life Podcast was recorded live at the American Academy of Neurology's Annual Meeting in 2025! Hosts Dr. Daniel Correa and Dr. Katy Peters were joined by Joel Salinas, MD, MBA, MSc, FAAN, Andrea Lendaris, MD, MS, Andrew M. Southerland, MD, FAAN, and Eric J. Seachrist, MD to share what it's like living and practicing neurology with their own neurological condition(s) and neurodiverse perspectives, and explore how their experiences serve as a window into the patient and community perspective.   Brain & Life Articles Mentioned Neurology® Podcast Switching Roles: A Neuro-oncologist Reflects on his Own Experience with a Brain Tumor We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

What makes us who we are?Through the stories of seven of his patients, acclaimed Oxford University neurologist Masud Husain shows us how our brains create, change and can even restore our identity. Husain introduces us to a man who ran out of words, a woman who lost all inhibitions and another who believed she was having an affair with the man who was really her husband.These compelling human dramas reveal how our identities are created by different functions within the brain. It will ignite new ideas about who we really are – and why we act in the ways we do. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

What makes us who we are?Through the stories of seven of his patients, acclaimed Oxford University neurologist Masud Husain shows us how our brains create, change and can even restore our identity. Husain introduces us to a man who ran out of words, a woman who lost all inhibitions and another who believed she was having an affair with the man who was really her husband.These compelling human dramas reveal how our identities are created by different functions within the brain. It will ignite new ideas about who we really are – and why we act in the ways we do. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

What makes us who we are?Through the stories of seven of his patients, acclaimed Oxford University neurologist Masud Husain shows us how our brains create, change and can even restore our identity. Husain introduces us to a man who ran out of words, a woman who lost all inhibitions and another who believed she was having an affair with the man who was really her husband.These compelling human dramas reveal how our identities are created by different functions within the brain. It will ignite new ideas about who we really are – and why we act in the ways we do. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science

What makes us who we are?Through the stories of seven of his patients, acclaimed Oxford University neurologist Masud Husain shows us how our brains create, change and can even restore our identity. Husain introduces us to a man who ran out of words, a woman who lost all inhibitions and another who believed she was having an affair with the man who was really her husband.These compelling human dramas reveal how our identities are created by different functions within the brain. It will ignite new ideas about who we really are – and why we act in the ways we do. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/psychology

What makes us who we are?Through the stories of seven of his patients, acclaimed Oxford University neurologist Masud Husain shows us how our brains create, change and can even restore our identity. Husain introduces us to a man who ran out of words, a woman who lost all inhibitions and another who believed she was having an affair with the man who was really her husband.These compelling human dramas reveal how our identities are created by different functions within the brain. It will ignite new ideas about who we really are – and why we act in the ways we do. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/neuroscience

Do you tend to put tasks on the long finger? Neuroscientist Dr Sabina Brennan explains why we procrastinate. She outlines some different types of procrastination like Productive Procrastination and Pleasure-Seeking Procrastination and offers solutions for the one in five of us who have problematic procrastination.

Today's episode is a MUST listen.  This is one of the most important conversations you will ever hear about Alzheimer's prevention, dementia, memory loss, and brain health.  If you're worried about your memory, your parents' memory, or your risk of cognitive decline as you age, this episode gives you something most conversations don't: real hope, backed by science, and a clear plan you can start today.  In this powerful episode, Mel sits down with world‑renowned neurologists Dr. Ayesha Sherzai and Dr. Dean Sherzai, two of the leading medical experts in Alzheimer's disease, dementia, and cognitive decline.  Together, they break down what dementia actually is, how Alzheimer's fits into it, and why brain decline often begins 20+ years before symptoms appear - long before most people think to pay attention to brain health.  Dr. Ayesha and Dr. Dean explain how brain health is not determined by genetics alone, and why your daily habits have the power to prevent, slow, and even pause cognitive decline.  They share the exact science‑backed framework they teach their patients, built around five simple pillars of brain health using one unforgettable acronym: NEURO.  You'll also learn how to tell the difference between normal forgetfulness (like walking into a room and forgetting why) and early warning signs of dementia that should prompt a doctor visit.  And if you're a caregiver - or love someone who is - this episode is essential listening. The doctors explain why caregivers face a significantly higher risk of cognitive decline, how chronic stress and poor sleep damage the brain, and what you can do to protect your own memory while caring for others.  In this episode, you'll learn: - How to prevent Alzheimer's disease and slow cognitive decline using science‑backed daily habits - The difference between normal age‑related forgetfulness and early warning signs of dementia - What dementia actually is, how Alzheimer's fits into it, and why brain decline can start decades before symptoms - Why genetics are not your destiny when it comes to memory loss and brain health - The NEURO framework neurologists use to protect memory and reduce Alzheimer's risk - How exercise, deep sleep, stress reduction, and nutrition physically grow new brain connections There is so much good news in the research. There are simple, free things you can do starting today - even while listening -  that can reduce dementia risk by up to 53% and dramatically improve long‑term brain health. If you're concerned about Alzheimer's, dementia, memory loss, or your cognitive future - this is the conversation you need. For more resources related to today's episode, click here for the podcast episode page.   If you liked the episode, check out this one with neuroscientist, Dr. Wendy Suzuki next:  Change Your Brain: #1 Neuroscientist's Exercise Protocol for Peak Energy and Focus Connect with Mel:     Order Mel's new product, Pure Genius Protein Get Mel's newsletter, packed with tools, coaching, and inspiration. Get Mel's #1 bestselling book, The Let Them Theory Watch the episodes on YouTube Follow Mel on Instagram  The Mel Robbins Podcast Instagram Mel's TikTok  Subscribe to SiriusXM Podcasts+ to listen to new episodes ad-free Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

If you have ever walked out of a neurology appointment with a new prescription and a follow up three months away and thought, something is still missing, this episode is for you. In this episode Debbie Waidl, Migraine Freedom Expert and founder of the Freedom From Migraines Method®, shares the two questions she would ask your neurologist if she had five minutes with them before your next appointment. Not to challenge their expertise. Not to argue with their approach. But to change the entire direction of your care. Because the question most neurologists are trained to ask is what medication will manage this pain. And they are genuinely excellent at answering it. But that question is not the one that actually changes anything long term. The question that changes everything is why does this keep happening. In this episode you will hear: Why the fifteen minute appointment is not failing you on purpose and what it actually cannot do for you no matter how skilled your doctor is The two questions that shift the entire conversation from symptom management to root cause resolution What Debbie hears from women who have seen five, ten, even the best specialists in the country and still never had this conversation What a different kind of appointment looks like and why the goal matters as much as the plan This is not about choosing between your neurologist and a different approach. It is about understanding the gap between the two and making sure someone in your corner is filling it. Resources: FREE DOWNLOAD: Toxic Migraine Triggers Guide Get the complete guide showing you the hidden inflammatory triggers fueling your migraines, including toxins in your medication, environment, and everyday life. https://dwvirtualguide.com/free-guide Book a Free Migraine Breakthrough® Assessment: Let's assess your unique migraine situation and uncover what's been keeping you stuck. https://pages.debbiewaidlcoach.com/breakthroughcall Connect with Debbie: Instagram: https://www.instagram.com/debbiewaidl.coach/ Women's Migraine Freedom™ Facebook Group: https://www.facebook.com/groups/womensmigrainefreedom Website: https://pages.debbiewaidlcoach.com/ Email: freedom@debbiewaidl.com Disclaimer: The Migraine Freedom™ Your Way Podcast and information provided by Debbie Waidl and guests is presented solely to provide helpful information, education, and entertainment on the subjects discussed. The use of information or resources mentioned on or linked from this podcast is at the user's own risk and discretion. This podcast is not intended to diagnose or treat any medical condition. For diagnosis or treatment of any medical problem, consult your own physician. Debbie Waidl and In The Balance Health Coaching, LLC are not responsible for any medical conditions or liable for any damages or negative consequences from any treatment, action, application, or preparation to any person reading or following the information presented on this podcast. References are provided for informational purposes only and do not constitute an endorsement of any websites or other sources.  

India's top neurologist Dr. Neha Pandita sits down with Gaurav Arora on xMonks Drive, and she has something to say about Deepinder Goyal's Temple device.When the founder of Zomato started wearing a brain-monitoring device on his temple to track blood flow and slow ageing, the internet had opinions. But what does an actual movement disorder specialist think? Dr. Pandita's reaction was simple: she laughed. Not because the idea is stupid, but because one artery cannot tell you everything happening inside your brain, and the science isn't there yet.But that's just where this conversation starts.Dr. Neha Pandita is one of India's leading neurologists and movement disorder specialists. She has spent over two decades studying the brain, and she herself was diagnosed with writer's dystonia during her MBBS finals, the very disorder she now treats in others. She saved a passenger's life mid-flight with a newborn in her arms. She has watched a Parkinson's patient sing again after years of silence. And she grew up as a Kashmiri Pandit refugee, starting from zero in Himachal Pradesh.In this episode she breaks down everything you thought you knew about your brain, and most of it is wrong.What you'll learn:— Why heartbreak has nothing to do with your heart— What actually causes laziness, lack of motivation, and brain fog— The truth about Deepinder Goyal's Temple brain device— What Parkinson's disease really looks like inside a family— How deep brain stimulation works, and the sound doctors listen for inside the brain— Whether psychedelics can actually heal trauma— The myth of the male vs female brain— What memory loss really means, and when to see a neurologist— Why a 95-year-old survives when a 40-year-old doesn't— How close we actually are to curing Alzheimer's and Parkinson'sTimestamps00:00 Brain Hacking Hype01:31 Temple Wearable Explained01:51 Why Evidence Matters03:17 Temporal Artery Oversimplified03:57 Tech Claims vs Mental Health06:01 Neurology Basics and Mislabels08:11 Warning Signs to Watch11:05 Motivation Stress Sleep Link13:19 New Discoveries Curable Disorders16:18 Deep Brain Stimulation Story18:50 Inside Awake DBS Surgery22:26 Neuroplasticity and Stimulation Limits23:55 Psychedelics Reality Check25:20 Brain Beyond Final Frontier26:48 In-Flight Medical Emergency31:10 Living With Writer Dystonia34:28 Why Neurology Felt Right38:49 Parkinson's Patient Breakthrough44:09 Near-Death Pregnancy Complication46:55 Science Faith and Letting Go48:15 Closing Gratitude and TakeawaysAbout Dr. Neha Pandita Dr. Neha Pandita is a neurologist and movement disorder specialist based in India. She specialises in Parkinson's disease, dystonia, deep brain stimulation, and neurodegenerative disorders. She completed her MBBS, DNB, DM Neurology, and a fellowship in movement disorders, and has been practising for over fifteen years.Keywords: Deepinder Goyal Temple device, brain hacking India, neurologist reacts, Dr Neha Pandita, xMonks Drive, Gaurav Arora podcast, neurology India, Parkinson's disease India, deep brain stimulation explained, writer's dystonia, brain health tips, movement disorder specialist India, Zomato founder brain device, how the brain works, dopamine serotonin explained, Alzheimer's India, brain myths debunked, Indian podcast, motivation and the brain, Kashmiri Pandit story, Indian neurologist, DBS surgery explained, psychedelics and the brain, ne

What if your cravings aren't a problem to fix, but a signal you've been ignoring?Dr. Katie Deming sits down with Dr. Natasha Campbell-McBride, a researcher whose work connecting nutrition, gut health, and chronic illness has reached people around the world.Together, they dig into why some of the most widely accepted dietary advice may be working against healing, not for it. Specifically, they explore what happens when the body is deprived of the nutrients it actually needs to repair and rebuild at the cellular level.Dr. Katie shares what she's observed firsthand in her own fasting practice, including something that surprised even the most committed plant-based patients who came to her for care. Chapters:00:04:50 - The Signal Your Body Sends When Cleansing Is Over00:05:18 - Why Your Hunger Might Be Misleading You00:06:30 - The Refeeding Step Most People Get Wrong00:07:27 - Why People Crave Meat After Prolong Fasts00:09:05 - The Refeeding Approach That Changes Recovery00:10:30 - The Hidden Risk in Nuts and Seeds00:11:19 - The Cooking Oil Problem00:14:00 - Why We are Conditioned to Fear Fat00:21:30 - What Happens When Your Gut Loses BalanceDr. Natasha brings decades of research to explain what's really going on inside the body when cravings show up, and what those cravings are actually trying to tell you. If you've ever felt confused by conflicting nutrition advice, this conversation will help you understand why.The conversation takes a hard look at cholesterol, what it actually does in the body, why your levels may not mean what you've been told, and how the standard advice around it could be getting in the way of your healing. Press play because the final topic on the gut microbiome ties everything together in a way that reframes how you think about disease itself.Connect with guest: www.drnatasha.comAccess the FREE Water Fasting Masterclass Now: https://www.katiedeming.com/the-healing-power-of-fasting/Ready to try fasting but don't want to do it alone? Join Dr. Katie's 3-Day Guided Fast, for expert support, daily live calls, and a community to fast alongside: Sign-Up  Download the FREE Healing Tools Guide: https://bit.ly/drkatie-giftguideMORE FROM KATIE DEMING M.D.6 Pillars of Healing Cancer Workshop Series - Click Here to EnrollTransform your hydration with the Spring Aqua System:  https://springaqua.info/drkatieFollow Dr. Katie Deming on Instagram: https://www.instagram.com/katiedemingmd/Please Support the ShowShare this episode with friends & familyGive a Review on SpotifyGive a Review on Apple PodcastWatch on YoutubeDISCLAIMER: The Born to Heal Podcast  is intended for informational purposes only and is not a substitute for seeking professional medical advice, di...

In this episode, Duane Mancini speaks with vascular neurologist Anit Behera about what it takes to improve stroke care from the ER through long-term recovery. Anit shares his path through an MD-PhD in outcomes research, how consulting and clinical trials shaped his innovation mindset, and why stroke care advancement spans four phases: prevention, acute treatment, post-acute care, and rehabilitation. He explains where he sees major opportunity next, pointing to emerging devices and research in post-stroke rehab alongside stronger prevention strategies and better health literacy. The conversation also breaks down how clinicians evaluate new technologies, emphasizing rigorous data, patient safety, and real-world workflow fit, plus the role of key opinion leaders and conferences in driving adoption. Anit Behera LinkedInDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedInThank you to our sponsors: Ward Law and JumpStart Inc.

A neurologist's private journal becomes a powerful window into the human side of medicine—revealing patient stories, emotional realities, and the unseen moments that shape care.Dr. Carolyn Larkin Taylor shares insights from her decades in neurology, including Alzheimer's, hallucinations, and the importance of connection between doctors, patients, and families.Podcast: Chatting with Betsy | Passionate World Talk Radio NetworkBecome a supporter of this podcast: https://www.spreaker.com/podcast/chatting-with-betsy--4211847/support.

Dr. Greg Cooper and Dr. Sara Hassani discuss periprocedural brain health and call on neurologists to engage in multidisciplinary efforts to improve periprocedural outcomes. Show citation: Hassani S, Gorelick PB. Periprocedural Brain Health: The Scope of the Problem and the Neurologist's Role. Neurology. 2025;105(12):e214427. doi:10.1212/WNL.0000000000214427   Show transcript: Dr. Greg Cooper: Hi, this is Greg Cooper. I just finished interviewing Sara Hassani for this week's Neurology Podcast. For today's Neurology minutes, Sara, I'm hoping you can tell us the main points of your paper. Dr. Sara Hassani:  I would say that the central message of this paper is that paraprocedural neurologic complications, they're very common, and they may actually be as high as the third leading cause of mortality, and yet very few healthcare providers realize this. And furthermore, few healthcare providers are adequately prepared to discuss the risks of the various procedures with patients and/or their family members. Dr. Greg Cooper: Thank you for that summary and all your work on this topic. Please check out this week's podcast to hear the full interview, and read the full article published in Neurology, Paraprocedural Brain Health. Thank you. 

Neurologic complications of substance use may be the first symptoms that lead patients with substance use disorders to seek care. Neurologists have a key role in identifying patients with substance use disorders and connecting them to treatment. In this episode, Lyell K. Jones Jr, MD, FAAN, speaks with Adeline L. Goss, MD, author of the article "Neurologic Complications of Drug and Alcohol Use" in the Continuum® February 2026 Neurology of Systemic Disease issue. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Goss is a neurohospitalist and associate chief of neurology for Highland Hospital in Oakland, California. Additional Resources Read the article: Neurologic Complications of Drug and Alcohol Use Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ Full episode transcript available here Dr Jones: A big part of neurology is solving mysteries. Patients can show up with all kinds of mysterious symptoms. Sometimes the diagnosis comes from within, some internal disruption of neurophysiology. But sometimes the problem is a complication of drug or alcohol use. Today we have the pleasure of speaking with Dr Adeline Goss, who recently authored an article for Continuum on this exact problem, a topic all neurologists need to be familiar with. Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum: Lifelong Learning in Neurology. Today I'm interviewing Dr Adeline Goss, who recently authored an article on the neurologic complications of drug and alcohol use for our latest issue of Continuum on the neurology of systemic disease. Dr Goss is a neurohospitalist and the associate chief of neurology at Highland Hospital in Oakland, California. She's also an accomplished writer, broadcaster and podcaster. Dr Goss, welcome, and thank you for joining us today. Why don't you introduce yourself to our listeners? Dr Goss: Great to speak with you, Dr Jones. Yes, I'm Adeline. I also go by Addie Goss. Dr Jones: So, before we get into the discussion, we're going to start off today with something fairly new to the podcast, the Continuum Audio trivia question. So, we all know that alcohol and other substances have many potential complications in that use of these substances fluctuates over time. But this one stood out to me from your article, Dr Goss, just for the sheer size of the change. So, for our listeners, here's the question. Accidental exposures to what substance increased a whopping 1,375% between 2017 and 2021? I'll read that again. Accidental exposures to what substance increased 1,375% between 2017 and 2021? So, stick around to the end of our interview for the answer. And let's get right to it, Dr Goss. If you had a single most important message to our listeners from your article, what would it be? Dr Goss: Well, I mean, many of us went into neurology because of the way that neurologic illnesses can be life-changing for patients. And I work as a neurohospitalist at a public hospital in Oakland, California. Many of my patients are admitted for neurologic conditions related to substance use. And when I see my patients later in the discharge clinic, many tell me that the last day that they used meth or the last day they used cocaine, the last day they smoked, was the day they had their stroke or whatever they came into the hospital for. I think the most important message is that hospitalization for a neurologic condition related to substance use can interrupt use patterns, can motivate change. And therefore, as neurologists, we really have an opportunity to connect to our patients and connect our patients to substance use treatment and make a dramatic difference in people's lives in this regard. Dr Jones: I think that's a fantastic point. I enjoyed a point you made in your article---and I can't remember exactly how you phrased it, I won't say it as well---that you think of the syndromes through which alcohol and drug exposures can present. Those syndromes almost always could end up of other primary neurologic disorders. So, put a different way, when a patient presents with a neurologic problem, most of the time an exposure could be on the differential.  And so, we really do have a responsibility as neurologists to be familiar with these. Dr Goss: To be familiar with these and to know how to connect patients to resources to try to get treatment. Dr Jones: Totally agree. And you touched on the public health aspect of this. It's really hard to talk about drug or alcohol use without acknowledging the public health impact particularly of opioids, which has been a crisis for most of this century. Right? And I think most of our listeners will be familiar with the rapid rise in opioid-related deaths. But there might be a glimmer of optimism there. Is what I've seen true, that opioid-related deaths may have plateaued? Dr Goss: So, yes, it's true that opioid-related deaths, overdose deaths in general, have begun to decline, actually, since 2023. And that's in part because overdose deaths really surged early on in the Covid-19 pandemic, in the setting of all of the social disruption, reduced access to services, and social isolation that occurred with the pandemic. But there were really multiple factors there. So, as you mentioned, there was this really rapid rise in illicitly manufactured fentanyl. Fentanyl became a major driver in overdose deaths starting in the mid-2010s. And by the late 2010s, it overtook heroin and prescription opioids as drivers of overdose deaths. And then this just collided with the pandemic in 2020, causing skyrocketing deaths. So, as we know as neurologists, fentanyl is more potent, it's shorter-acting, and it's also cheaper than heroin. It can cost as little as 50 cents or a dollar a pill. Thankfully, as services have rebooted and also as naloxone has become more widely distributed, there has begun to be a decline in opioid overdose-related deaths. So, we're relying on provisional data from the CDC for the most recent years, but that shows about a 24% decline in annual overdose deaths, comparing late 2023 to late 2024. And that's real. That comes out to 70 lives saved per day. Unfortunately, deaths still remain above prepandemic levels, and we're still talking about 87,000 drug overdoses per year. So, I would agree, a glimmer of hope. But we're still seeing overdose as the leading cause of death among young Americans aged 18 to 44. And there's a very long way to go. Dr Jones: 23% is a big number, and that is certainly exciting to think about, but we're still above that long-term secular trend. So, hopefully whatever is happening to bring that down, hopefully it continues. And we talk a lot about- appropriately, we talk a lot about opioid exposures and some of the neurologic presentations of opioid use and toxicity, but alcohol use disorder is the most common substance use disorder, correct? I learned that from your article. And it has been for some time, and it has well-known acute and chronic toxicities. But I think many of us have been taught something of a myth in the acute treatment of patients who may have thiamin deficiency or Wernicke's encephalopathy. Can you tell us a little more about that? Dr Goss: Yeah, sure. So, boy, what is my favorite vitamin? As a neurologist, I think thiamin is my favorite vitamin. Thiamin is a cofactor in- for several enzymes that are involved in glucose catabolism. And it's necessary to synthesize myelin and several neurotransmitters. And as we know, alcohol use disorder leads to reduced nutritional intake and impaired digestion and absorption of nutrients. And this can lead to deficiencies in water-soluble B vitamins, including thiamin, as well as trace elements. The thing about thiamin is that thiamin deficiency often appears first, because the body's stores of thiamin deplete in about 4 to 6 weeks. You know, we're traditionally taught if a patient presents with symptoms concerning for Wernicke's encephalopathy, that if they're also hypoglycemic or just in general, we have to get glucose into them first, because we don't want to tax these thiamin-dependent glucose catabolism pathways. But really, there's no reported case of a single glucose bolus precipitating some dramatic symptomatic thiamin deficiency. It's thought that harm would come potentially from prolonged carbohydrate administration without thiamin. And so, if a patient in front of you is both thiamin deficient and hypoglycemic, you just treat both. You treat both emergently. But it doesn't really matter in what order you do so. Dr Jones: That's good to know that doing the right thing for the patient can involve using either of those in whatever order. And I agree with you, I don't think I've ever hurt anybody by giving them thiamin. It's an easy one to miss and an important one to remember in the right context. And speaking of, and I think a lot about in your article, Dr Goss, I can see a neurologist seeing a patient in the emergency department or in the hospital or even in the clinic thinking about the wonderful points in your article. But we know that when alcohol or substance use enters our mind on the differential, the next impulse is to test for it. And we also know there are pitfalls of drug screening, doing urine drug screens, etc. How do you approach testing when you think about a potential drug-related complication in their differential? Dr Goss: So, like most people, I would start with a urine drug screen for any patient who's presenting with a possible toxidrome or some substance-related neurological presentation. These urine drug screens, they're rapid, they're inexpensive, they're immunoassays for traditional drugs and their metabolites. So, usually amphetamines, cocaine, opiates, plus/minus cannabis. But I think the first thing to note is that they miss entire categories of drugs, and not just drugs that are not in that list. They miss synthetic opioids, including fentanyl. One group is keeping track of this number. So, I have an update for mid-2025. And that's that 30% of U.S. ED overdose encounters as of mid-2025 included fentanyl testing. Only 30% for patients who are presenting with an overdose syndrome. Dr Jones: And that's for one of the most widely used synthetic opioids. So that's really a striking number. Dr Goss: Yeah, one of the most widely used and one with the greatest rate of complications. So, states can make a difference here. In 2022, California passed a law requiring fentanyl testing on hospital urine drug screens and several states have followed. And so that number is rising, the rate of testing for fentanyl. But that's just a really key thing to know, that that one is often missed. Other just important pitfalls, the timing of the urine drug screen matters because for most substances, it only picks up the drug within 24 to 72 hours after the last use. With amphetamines and cocaine going out a couple more days after that, especially in patients who use repeatedly. And then also, notably, there's a risk of false positives. This is especially true with amphetamine use, and beta blockers are one of the drugs that can lead to false positives on an amphetamine test, on a urine drug screen. So, I'll share that I've had several patients who have presented with intracerebral hemorrhage and who tested positive on the emergency department's urine drug screen and who adamantly stated that they do not use amphetamines, they've never used amphetamines, and they didn't ingest anything that could have contained amphetamines. And when we did serum confirmatory testing, in fact, their amphetamine testing was negative, and all those patients had received esmelol or the labetalol in the ED to treat their blood pressure related to their ICH. So false positives can occur with, you know, other medications like decongestants and certain antidepressants. But beta blockers are a key one to know. And then finally, there are just a number of things outside of that short list of substances that I mentioned, including a huge range of novel psychoactive substances that would not be tested for on a standard urine drug screen. And for those, you'd require serum testing, or at some large academic centers or specialty toxicology labs, you can actually do liquid chromatography high-resolution mass spectrometry, with- which is basically unbiased testing for any substance that's present in the patient sample. So, I guess, you know, you asked about my approach. Start with the urine drug screen, but there's no substitute for good history-taking and close examination of your patient's general examination, not just their neurologic presentation. And if patients are presenting with a toxidrome that I would expect would show up on a urine drug screen but it's negative, there are other confirmatory tests that can be sent, although they're often send-out labs and come back in a very delayed fashion. Dr Jones: So, in other words, it's complicated, which usually means it's humbling. And if I'm understanding it correctly, there's the risk of the false positive on the urine drug screen. And then there's the risk of the false negative if we think we're screening for something that might not even be on that initial screen. So, that's a wonderful reminder that these are clinical diagnoses and we have to keep our clinician hats on while we're thinking about how to establish these diagnoses or exclude them. So, back to opioids, Dr Gross. There are some really peculiar neurologic syndromes associated with opioid overdose. Tell us a little about those. Dr Goss: Well, I mean, some of these were described first with heroin. So, we can start with the one that almost anybody has heard of, heroin-associated spongiform leukoencephalopathy, which we know is associated with a practice known as "chasing the dragon," which is inhaling vapors of heroin heated on foil. But we know now that this syndrome can occur with other opioids, including fentanyl. The clinical features are, you know, apathy, cerebellar signs, quadriparesis, parkinsonism, myoclonus, and some patients progress to coma or even death. But on MRI you're seeing, you know, these confluence symmetric white matter diffusion restriction and T2 hyperintensities in the cerebellar white matter and the posterior limb of the internal capsule that spare the subcortical U-fibers. So, you know, I think this is kind of the classic example of something that's symmetric, that has a very obvious and interesting MRI pattern. But as time is passing, we're seeing more and more similar types of syndromes of leukoencephalopathies, but with different clinical presentations and MRI characteristics. So, another of these is CHANTER syndrome. This is an opioid overdose-related presentation where people have stupor and coma. And on the MRI there, you see bilateral symmetric diffusion restriction in the cerebellar cortex, in the hippocampi, in the basal ganglia. And it spares the cerebral cortex. And notably in these cases, patients can progress to cerebellar edema, to obstructive hydrocephalus. And some require suboccipital craniotomy. I had a week recently at Highland Hospital, where I work, where we had two of these cases in the same week, in just a community hospital. And there's a similar syndrome in children known as POUNCE syndrome with profound cerebellar edema, and many patients require posterior decompression. So that's another different distribution of findings with a different outcome. Fortunately, there's a milder sort of phenotype of opioid-associated amnestic syndrome, is what it's been described, where there's primarily DWI changes in the hippocampi and the globus pallidus. So, patients primarily present with an amnestic syndrome, mostly anterograde amnesia. Seeing these in practice, I'm not sure that patients always fall into one bucket or another. But in general, you'll see some degree of symmetric diffusion restriction or symmetric white matter changes that clearly point to a toxic presentation, a toxic syndrome, as opposed to pure anoxia, for example. And it's important to know that because from a prognostic standpoint, anoxic brain injury, which can occur after cardiac arrest and after opioid overdose, can look different than some of these syndromes. Finally, heroin has been associated with myelopathy, but also that's been reported on with fentanyl. So, I think some of these conditions got their reputation from heroin. But as fentanyl has proliferated---and prior to that as prescription opioid, you know, misuse had proliferated---we're seeing similar syndromes with all of the opiates. Dr Jones: And I think it's a good case in point that you can have multifocal disease and it be a manifestation of an intoxication, and I think that's a really good reminder that we have to have many of these syndromes in our differential, we have to be aware of them, otherwise we might miss them or attribute them to another mechanism. Dr Goss, our last issue of Continuum that was dedicated to the neurology of systemic disease came out in 2023, and here we are in 2026 publishing our latest issue, including your article and this podcast. Since 2023, have there been any emerging patterns or novel agents of abuse or misuse out there? Dr Goss: The short answer is yes, and I would say the reason is just the supply is moving at more and more rapid speed. The relationship between the internet and drug supply has really informed what's out there at any given moment. So, the turnover in the market can change in weeks, not in years. And there's all of this distribution through social media and encrypted apps. And then manufacturers are kind of continuously tweaking chemical structures to evade law enforcement. In the process of researching this article, I came across some, I mean, really wild examples. To be clear, these are not- not all these are common substances, but I think the general phenomenon should be known that people can walk into a vape shop or walk into a gas station or meander around online and buy some really weird stuff. So, in 2024, there was this nationwide recall of a product called Diamond Shrooms that was sold online and in smoke and vape shops, and this was billed as, like, a hemp and mushroom mixture. But it led to multiple- I mean, over 100 cases of seizures and agitation and depressed consciousness and a few possible deaths. And when the contents were analyzed, they included psilocybin analogs and pregabalin. I mean, some weird stuff. And so, those have been pulled. But people are constantly inventing and marketing these different substances. I think another example… we all know about nitrous oxide and its association with B12 myopathy. But the use of nitrous oxide has really changed. Companies are selling large canisters online and in vape shops, and they're flavored, like, in blue raspberry flavor. And unfortunately, there's been a rise of nitrous among youth. So, we're seeing not just increased cases of myelopathy, but also a 2025 study in JAMA found a spike in deaths attributed to actual nitrous oxide overdose. And so nitrous, I think, had not been that commonly used a few years ago, but has become more common in the last couple of years. A final one I'll just mention is ketamine. So, ketamine has certainly appeared in reviews of neurological syndromes related to substance use for a long time, and it's also been studied and used off-label for mood disorders in outpatient infusion clinics for some time. But in the pandemic, there was an expansion in telemedicine, as we know, and an associated proliferation of teleclinics that were prescribing very frequent, even daily oral and lozenge and nasal formulations of ketamine, which has led to increased rates of misuse. So, you know, acutely, the syndrome associated with ketamine intoxication is very brief. And often by the time people come to the emergency department, their symptoms have already worn off. But long-term, frequent use of ketamine is really still being studied. There seems to be an association with persistent neuropsychiatric effects like cognitive impairment, psychosis, persistent depressive symptoms. And so, you know, I think it's just important to realize that while the list of substances may look pretty similar to 2023, the use patterns, the distribution patterns are continuing to change. It's hard to keep up. And while alcohol and opioids and stimulants are by far the most common substances that a neurologist is going to encounter in daily practice, there's this ever-expanding range of possible substances that can trigger neurologic syndromes, both acute and chronic. Dr Jones: And I think that might be the best possible plug to read your article, because it is evolving and we have to stay on top of it. And we really can't be complacent with it. So, thank you for that update. Okay, back to our trivia question. Accidental exposures to what substance increased a whopping 1,375% between 2017 and 2021? Dr Goss, what do you think? Dr Goss: That was THC-infused edibles. Specifically, these would be THC-infused substances that are often marketed as looking like candy or snacks or cereal. Exactly what a kid might want to get their hands on. And unfortunately, accidental cannabis exposures in children under age five went up by 1,375% between 2017 and 2021, and 600 of those patients required critical care admission. Dr Jones: Yeah. So, just a mind-blowing number, and obviously something for us to be on the lookout for, especially if you see children in your practice and someone comes in with CNS depression or stupor, it's one to not miss. So that was something I learned in reading your article, among many other things. And Dr Goss, I want to thank you for joining us. I want to thank you for such a great discussion. I learned a lot from reading your article, I learned a lot just from our conversation today, and I suspect our readers and our listeners will too. Dr Goss: What a pleasure. Thank you so much, Dr Jones. Dr Jones: Again, we've been speaking with Dr Adeline Gross, author of a fantastic article on neurologic complications of drug and alcohol use in our latest issue of Continuum on the neurology of systemic disease. Please check it out, and thank you to our listeners for joining us today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

What if the most common nutrition advice given to people facing chronic illness, eat more plants, is actually working against healing?Host Dr. Katie Deming sits down with Dr. Natasha Campbell-McBride, neurologist, nutritionist, and creator of the GAPS Protocol, to question whether the human gut is truly designed to rely on plant-based nutrition during healing.They explore what traditional cultures prioritized for recovery, why some foods may be harder for the body to process than we think, and how modern dietary guidelines may be shaped by forces beyond patient health.Chapters: 00:04:05 - What Your Body Can't Digest 00:06:20 - The Food That Actually Builds You 00:08:25 - The Truth About Vegan Diets 00:10:15 - Who Controls Your Food Choices 00:13:40 - The Profit Behind Your Diet 00:17:45 - Why Doctors Stay Silent 00:22:10 - Treating Symptoms or HealingIf you're facing chronic illness, supporting someone who is, or trying to understand what your body needs during recovery, this episode challenges conventional thinking around food and healing.Press play and learn what may be missing when certain foods are removed, and why that matters most when your body is under stress.Connect with Guest: https://www.doctor-natasha.com/Access the FREE Water Fasting Masterclass Now: https://www.katiedeming.com/the-healing-power-of-fasting/Ready to try fasting but don't want to do it alone? Join Dr. Katie's 3-Day Guided Fast, for expert support, daily live calls, and a community to fast alongside: Sign-Up  Download the FREE Healing Tools Guide: https://bit.ly/drkatie-giftguideMORE FROM KATIE DEMING M.D.6 Pillars of Healing Cancer Workshop Series - Click Here to EnrollTransform your hydration with the Spring Aqua System:  https://springaqua.info/drkatieFollow Dr. Katie Deming on Instagram: https://www.instagram.com/katiedemingmd/Please Support the ShowShare this episode with friends & familyGive a Review on SpotifyGive a Review on Apple PodcastWatch on YoutubeDISCLAIMER: The Born to Heal Podcast  is intended for informational purposes only and is not a substitute for seeking professional medical advice, di...

Mortgage rates are on the move once again, and if you have an ARM that is coming up on a variable rate period, it may be time to consider changing your mortgage type. The answer to knowing if you should is easier than you may think. Nate Reineke and Chelsea Jones give you the one simple step to determining what is best for you in the long run. We also answer your colleagues' questions. A Neurologist in Georgia says, “I was revisiting my retirement benefits and I forgot that I had contributed to the 457 and not the 403b because my work matches "50% of your 457 Savings Plan contributions up to 4% of your eligible pay." I feel like I should max this out as well? We took the contribution to the 457 down to 0 in our 2nd to last visit. If we do max this out, would I contribute 8% to get the maximum contribution from work of 4%?” An OBGYN in New Jersey asks, “Do I actually need life insurance?” A Double Doctor Family in Florida wants to know, “Should we have our home purchase fund invested in the stock market?” Are you ready to turn worries about taxes and investing into a plan for college and retirement? If you're evaluating your options and want to learn more, visit physicianfamily.com and click 'Get Started' or you can ask a question of your own by emailing podcast@physicianfamily.com. See marketing disclosures at physicianfamily.com/disclosures

Neurologist Dr. Majid Fotuhi, author of The Invincible Brain, joins me to break down the most powerful lifestyle habits for protecting your brain, staying sharp as you age, and reducing your risk of dementia.15 Daily Steps to Lose Weight and Prevent Disease PDF: https://bit.ly/46XTn8f - Get my FREE eBook now!Subscribe to The Genius Life on YouTube! - http://youtube.com/maxlugavereWatch my new documentary Little Empty Boxes - https://www.maxlugavere.com/filmThis episode is proudly sponsored by:Wildgrain slow-fermented sourdough and fresh pastries go from freezer to bakery-level perfection in under 25 minutes. Yum! Get $30 off your first box and free croissants in every box at Wildgrain.com/MAX or use code MAX at checkout.Fatty15 provides C15:0, a naturally occurring fatty acid found in full-fat dairy that may support cellular health and longevity—get 15% off at http://fatty15.com/MAX with code MAX!

After Deborah Kan's mother, Alvera Kan, died in December of last year, the family donated her brain to UCSF to better understand what type of dementia she had. The answer came back with not just one diagnosis, but three different types of dementia: Alzheimer's disease, vascular dementia, and LATE. Kan and her sister, Susan Whitaker, are joined by Dr. Bruce Miller, director of the UCSF Edward and Pearl Fein Memory and Aging Center, and Dr. David Soleimani-Meigooni, a neurologist at UCSF's Memory and Aging Center and assistant professor focused on precision diagnosis in Alzheimer's and related neurodegenerative diseases. Miller's work has helped shape how clinicians identify and distinguish different forms of dementia, including frontotemporal dementia, while Soleimani-Meigooni's clinical and research work includes using imaging and biomarkers to better understand amyloid, tau and other drivers of cognitive decline.In this conversation with Kan and Whitaker, Miller and Soleimani-Meigooni discuss how dementia diagnosis can remain uncertain during life and how an autopsy can reveal multiple diseases. They underscores how common mixed dementias are, why symptoms such as getting lost or struggling with numbers can point to specific brain changes, and why better diagnostic tools are needed. They also highlight the lasting scientific value of brain donation, showing how one family's decision can contribute to more precise diagnoses, better biomarkers, and, ultimately, more individualized treatment approaches for future patients.---If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

What if the guy who literally wrote the book on asset allocation told you your biggest risk isn't the market…it's the person in your bathroom mirror? Neurologist-turned-market-historian William (Bill) Bernstein joins us for a fascinating conversation about his unlikely path from photochemistry to medicine to becoming the quiet godfather of Boglehead-style investing. He shares what shaped his "simple but not easy" philosophy, why he thinks all of investing is "half math, half Shakespeare," and how a homemade website in the 1990s turned into "The Intelligent Asset Allocator" and a second career. This episode covers: ✅ How a frustrated young scientist became a neurologist, then a financial theorist and writer ✅ Early investing mistakes (Palladium futures, hot funds, overconfidence) and what finally clicked ✅ The five hurdles from If You Can and why history and psychology matter as much as math  ✅ What makes a true bubble: social buzz, career-changing speculators, hostility to skeptics, wild predictions ✅ Predictions vs forecasts, and how Bill "called" the dot-com bubble and GFC without betting the farm ✅ His current mix: modest small/value tilts, cash/T-bills for sanity, and a TIPS ladder for 30 years of expenses ✅ Why a TIPS ladder feels different from a TIPS fund and why most investors still won't use one ✅ The 30-years-working / 30-years-retired "toy model" and why it implies 20–25%+ savings rates ✅ Teaching kids about money via your own behavior, crappy college jobs, and tiny three-fund portfolios ✅ A sober view of FIRE as a way out of the cubicle and into meaningful work—not a 36-year-old beach fantasy ====================   DEALS & DISCOUNTS FROM OUR TRUSTED PARTNERS   MONARCH MONEY The modern way to manage money! Monarch will change the way you organize your financial life. Track, budget, plan, and do more with your money – together. Get 50% off the first year using this link and entering code: CATCHINGUP50   For a full list of current deals and discounts from our partners, sponsors and affiliates, click here: catchinguptofi.com/our-partners    SUPPORT  THE  SHOW

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden and neurologist Dr. Majid Fotuhi discuss building an "Invincible Brain." Challenging the myth that cognitive decline is inevitable, Dr. Fotuhi outlines five pillars—exercise, sleep, nutrition, stress management, and brain training, proven to increase brain volume and neuroplasticity. The discussion highlights how racket sports and balance training activate the cerebellum to boost overall function and reduce Alzheimer's risk. By consistently challenging the nervous system, you can shift the aging paradigm, achieving mental sharpness and vitality well into your 80s and 90s. This is the blueprint for lifelong brain health.     For Audience ·       Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !      Takeaways ·       Cognitive decline is often driven by lifestyle factors. ·       Maintaining a healthy lifestyle can mitigate cognitive decline. ·       Physical activity, especially balance training, is crucial for brain health. ·       Aging should be viewed as an opportunity for growth, not decline. ·       Trauma and psychological health significantly impact cognitive function. ·       Neuroplasticity allows the brain to change and adapt throughout life. ·       Stress management techniques can improve brain function and resilience. ·       Mindset plays a critical role in how we perceive aging and health. ·       Engaging in new activities can enhance brain health and longevity. ·       Everyone has the potential to improve their cognitive abilities at any age.       Chapters 00:00 Introduction to Cognitive Health and Aging 04:46 The Five Pillars of Brain Health 08:41 Challenging the Brain for Longevity 11:28 Mindset Shift on Aging 14:24 Reversing Cognitive Decline 19:00 Understanding Trauma and Its Impact 23:32 Healing from Psychological Trauma 24:31 Neuroplasticity and the Brain's Ability to Change 28:17 Genetics and Neurotransmitter Functionality 31:35 Mastering Stress and Achieving Flow State 32:58 Mindset and Personal Growth 37:40 Agency and Joy in Life 39:46 Understanding Glutamate and Its Effects 43:12 Rebuilding the Brain and Cognitive Improvement   To learn more about Dr. Majid Fotuhi: Website: https://biologyoftrauma.com/ Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw      Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.

If you're a physician with at least 5 years of experience looking for a flexible, non-clinical, part-time medical-legal consulting role… ...Dr. Armin Feldman's Medical Legal Coaching program will guarantee to add $100K in additional income within 12 months without doing any expert witness work. Any doctor in any specialty can do this work. And if you don't reach that number, he'll work with you for free until you do, guaranteed. How can he make such a bold claim? It's simple, he gets results…  Dr. David exceeded his clinical income without sacrificing time in his full-time position. Dr. Anke retired from her practice while generating the same monthly consulting income.  And Dr. Elliott added meaningful consulting work without lowering his clinical income or job satisfaction. So, if you're a physician with 5+ years of experience and you want to find out exactly how to add $100K in additional consulting income in just 12 months, go to arminfeldman.com.                                                          =============== Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs.                                                                                                 =============== Neurologist and medical journalist Dr. Andrew Wilner shares a practical, experience-based guide to locum tenens work, based on decades of practice and long-term assignments. In this summit lecture, he explains why locums can be a powerful tool for flexibility and career control, whether you're early in practice, transitioning, or looking for a different rhythm without leaving clinical medicine. He breaks down the realities physicians often overlook until they live them: unpaid travel time, how to think about compensation beyond the daily rate, and the logistical and tax details that come with multi-state work. He also references his book on locum tenens, "The Locum Life", as a deeper resource for physicians considering this path, and answers common questions about housing, travel strategy, and walking into unfamiliar settings with confidence. You'll find links mentioned in the episode at nonclinicalphysicians.com/make-the-locum-life-better/

This episode revisits Dr. Sui Wong's insights on how the eyes are neural tissue that can reveal early signs of brain, vascular, and metabolic issues, and reframes migraine as a common, often invisible neurological condition that causes brain fog and cognitive symptoms. Actionable takeaways include scheduling regular dilated eye exams, stabilizing blood sugar, prioritizing sleep and retinal blood flow, reducing digital strain, and tracking migraine triggers to prevent worsening symptoms. In today's review of EP 342 with Dr. Sui Wong from August 2024, we cover:  • Why the eyes are considered an extension of the brain — and how the retina is neural tissue • How eye exams may provide early insight into overall neurological and vascular health • What drusen are, why small amounts can be age-related, and why monitoring retinal changes matters • The powerful idea that prevention begins before symptoms become severe • Why migraine is not “just a headache,” but a neurological condition affecting 1 in 7 people globally • The hidden symptoms of migraine — including brain fog, mood changes, word-finding difficulty, and cognitive slowing • Why migraine is a leading cause of disability in young women and often goes unrecognized • The connection between blood sugar regulation, sleep, stress, and neurological function • Practical ways to support long-term brain health through awareness, monitoring, and daily lifestyle habits • How small, consistent actions build cognitive resilience over time Welcome back to Season 15 of the Neuroscience Meets Social and Emotional Learning Podcast. I'm Andrea Samadi, and here we bridge the science behind social and emotional learning, emotional intelligence, and practical neuroscience—so we can create measurable improvements in well-being, achievement, productivity, and results. When we launched this podcast seven years ago, it was driven by a question I had never been taught to ask— not in school, not in business, and not in life: If results matter—and they matter now more than ever—how exactly are we using our brain to make these results happen? Most of us were taught what to do. Very few of us were taught how to think under pressure, how to regulate emotion, how to sustain motivation, or even how to produce consistent results without burning out. That question led me into a deep exploration of the mind–brain–results connection—and how neuroscience applies to everyday decisions, conversations, and performance. That's why this podcast exists. Each week, we bring you leading experts to break down complex science and translate it into practical strategies you can apply immediately. When the brain, body, and emotions are aligned, performance stops feeling forced—and starts to feel sustainable. Season 14 showed us what alignment looks like in real life. We looked at goals and mental direction, rewiring the brain, future-ready learning and leadership, self-leadership, which ALL led us to inner alignment. And now, Season 15 is about understanding how that alignment is built—so we can build it ourselves, using predictable, science-backed principles. Because alignment doesn't happen all at once. It happens by using a sequence. And when we understand the order of that sequence — we can replicate it. By repeating this sequence over and over again, until magically (or predictably) we notice our results have changed. Season 15 we've organized as a review roadmap, where each episode explores one foundational brain system—and each phase builds on the one before it. Season 15 Roadmap: Phase 1 — Regulation & Safety Phase 2 — Neurochemistry & Motivation Phase 3 — Movement, Learning & Cognition Phase 4 — Perception, Emotion & Social Intelligence Phase 5 — Integration, Insight & Meaning PHASE 1: REGULATION & SAFETY Staples: Sleep + Stress Regulation Core Question: Is the nervous system safe enough to learn? Anchor Episodes Episode 384[i] — Baland Jalal How learning begins: curiosity, sleep, imagination, creativity Episode 385[ii] — Bruce Perry “What happened to you?” — trauma, rhythm, relational safety Episode 387 Sui Wong Autonomic balance, lifestyle medicine, brain resilience Episode 388 Rohan Dixit HRV, real-time self-regulation, nervous system literacy Phase 1 — Regulation & Safety We have reviewed Dr. Baland Jalal where we were reminded that before learning can happen, before curiosity can emerge, before motivation or growth is possible—the brain must feel safe. Then we looked at trauma and relational safety with Dr. Bruce Perry's Book, What Happened to You, and we move onto Dr. Sui Wong, with autonomic balance, lifestyle medicine and brain resilience.

In the second installment of this three-part series, Dr. Stacey Clardy and Max Goldman discuss neuroscience research and the BRAIN Initiative.  Stay updated with everything related to Neurology on the Hill. Show transcript:  Dr. Stacey Clardy:  Hi, this is Stacey Clardy. We are going to continue with our three-part series today about the top advocacy issues covered at Neurology on the Hill 2026 in Washington, DC. Again, as many of you know, this is the AAN's annual advocacy fly-in event. Neurologists come from all over the US to Washington and meet with elected representatives to discuss issues of high importance to allow us to continue providing high-quality care to patients in the US with neurological diseases. In the first minute, we discuss the topic of Medicare, and I have with me again, Max Goldman, director of Congressional Affairs from the AAN legislative team, to talk to us about issue number two, which is neuroscience research, and specifically the BRAIN Initiative. Max, what are we going to discuss about neuroscience research? What do we need to happen in order to continue doing high-quality research? Max Goldman: So, this one is so important, and there's this wonderful program at the NIH called The BRAIN Initiative. This was founded in 2013, really reinforced in 2016 with the 21st Century Cures Act. It's just funding for basic research into how the brain works, right? And the idea behind this is that if we can understand how the brain works, we can find the next generation of treatment or cures for neurological conditions, psychiatric conditions, and issues that go through the brain. This year, we are in a precarious position. Mandatory funding for this program is expiring, and so we're going to lose a lot of money and a lot of opportunities to provide more grants to people to figure out how the brain works. So, what we are doing on Neurology on the Hill is we're asking members of Congress to support $468 million in funding in fiscal year 2027 for the BRAIN Initiative, so we can keep up the good work and keep working towards the next generation of treatments and cures for neurological conditions. Dr. Stacey Clardy: So important. Thank you, Max. To learn more about this issue and the other two issues, you can go to AAN.com. Click on advocacy. And stick with us for the third Neurology Minute, where we will get to the final issue to be discussed, telehealth. 

Join Sandra and enjoy this week’s show as you listen to the medical testimony of Dr. Adam Rizvi. He discusses everything from patients staying alive with near zero blood pressure to the room darkening or brightening when a soul departs.See omnystudio.com/listener for privacy information.

Join Sandra and enjoy this week’s show as you listen to the medical testimony of Dr. Adam Rizvi. He discusses everything from patients staying alive with near zero blood pressure to the room darkening or brightening when a soul departs.See omnystudio.com/listener for privacy information.

Welcome back to our weekend Cabral HouseCall shows!   This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track!   Check out today's questions:    Sheena: Hi Dr C! Hope you and your team are well. I've been hearing a lot about colostrum lately and it piqued my interest. Can you speak a little about it? Do you use it? Is there a brand you would recommend? Is it safe for anyone? Who should avoid it? Side effects? I take a probiotic everyday, can colostrum replace this?? Looking forward to hearing your response. Thanks in advance!                                                                                                                                                         Frankie: Hi Stephen, My name is Frankie Im 21 years old, and I wanted to follow up from Episode 3382, where you mentioned my symptoms could be connected to gut issues, low vitamin D, magnesium, metals, or GERD. Since then, I followed a strict LPR diet for about two months  no gluten, coffee, alcohol, peanuts, oats, onions, garlic, broccoli, beans, etc. My LPR symptoms improved by around 70%, and while I still have some mucus in my throat, its nowhere near as potent as before. During and after the protocol, I focused on rebuilding my gut with some gut-rebuilding supplements and slowly reintroducing foods. Its now been about three months since finishing the protocol, and Ive gained around 14 pounds. I also still deal with loose stool almost every day, which hasnt improved much. It’s honestly shocked me because Im very dialed in with both my food and workouts, yet the weight gain and digestive changes still happened. I wanted to get your thoughts on what direction to take from here. I havent run the Big 5 protocol since Im based in Canada, and it would end up costing quite a bit more with shipping and exchange rates. Also, I just wanted to mention its surprising how many young people my age are struggling with digestive and gut related issues. Its becoming way too common. Thanks again for all the work you do, and I hope you have a great day I listen to you every morning. Frankie     Gary: Hi Dr. Cabral. Im 49, male & over the last 4 years taken a deep interest in my health. I had cerebral malaria (2003) & as a result developed essential tremor both hands. Listened to 2 podcasts & working on noticeable triggers like ltd caffeine & alcohol. It hasnt got worse, but really is there any way to reverse it? Neurologist says surgery has no guarantee.  I would value the truth & if it were your wife what you would do please. So much life ahead 🙏 (PS. Partner is an IHP so DESTRESS at the heart of our approach) we want to do EVERYTHING we can. Thank you     Sienna: Hi Dr. Cabral - so excited about your new Pea Protein, got great feedback from the support team, however would love your response. Pea Protein safe for kids? Since DNS is I would approach it in same way, Dr. AI says generally kids get enough from food so not recommended… Do you give this to your daughters in same way you have it? Ie a little more protein in smoothies *daily* or just in baked goods like pancakes occasionally. Thank you! Happy holidays      Anonymous: What are some ways to improve gut motility, I'm already on a supplement program and ginger tea. Any thoughts on massage abdominal, hot stones, any other physical techniqes?     Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!      - - - Show Notes and Resources: StephenCabral.com/3634 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!